PMS-BUSULFAN 6mg/mL: impurity could be out of specification
Brand(s)
Last updated
Summary
Product
PMS-BUSULFAN 6mg/mL
Issue
Health products - Product quality
What to do
Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
Distribution
National
Affected products
| Product Name | Market Authorization | Dosage Form | Strength | Lot numbers |
|---|---|---|---|---|
| PMS-BUSULFAN | DIN 02477343 | Intravenous Solution | Busulfan 6mg/mL | 660609 & 662713 |
Issue
The content of an impurity could be out of specification before the expiry date in the affected lots.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Wholesalers
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies
Pharmascience Inc.
6111 avenue Royalmount, suite 100
Montréal, QC
H4P 2T4
Published by
Health Canada
Audience
General public
Healthcare
Distribution
National
Recall class
Type III
Recall date
Identification number
RA-82001
Get notified
Receive emails about new and updated recall and safety alerts.